The Leading NHP Partner for Advancing Preclinical Research with Precision and Integrity
At Envol Biomedical, we provide full-spectrum preclinical research solutions built on scientific precision, ethical integrity, and operational scale. As the largest provider of nonhuman primate (NHP) subjects in North America, Envol supports sponsors with unparalleled access to translational models, integrated laboratory services, and advanced surgical and imaging capabilities—all under one roof.
Our AAALAC-accredited, USDA-registered, and OLAW-compliant facilities ensure every study meets the highest standards of animal welfare and regulatory excellence. From discovery through IND-enabling development, our cross-functional teams deliver reliable, submission-ready data that accelerate timelines and reduce risk. Whether advancing a small molecule, biologic, or gene therapy, Envol provides the scientific partnership and infrastructure needed to turn breakthrough ideas into meaningful outcomes.
Recent Blogs
November 14, 2025
The Evolution of Primate Supply Chains: Envol Biomedical’s Jake McDonald to Present at ACT 2025
As one of the nation’s leading GLP toxicology partners, Envol Biomedical is proud to be...
November 13, 2025
Advancing CNS Drug Development: Envol Biomedical to Debut First-in-Kind NHP COFM Capabilities at ACT 2025
As one of the nation’s leading GLP toxicology partners and the largest provider of NHP...
November 12, 2025
The Ripple Effects of Uncertainty Around FDA Changes: Envol Biomedical and White Oak Regulatory Tox Present at ACT 2025
Few years in recent memory have tested the clarity and consistency of the FDA’s regulatory...Capabilities & Services
Envol Biomedical provides translational pharmacology services using nonhuman primate (NHP) models to generate precise, actionable data that advance drug development from discovery through IND-enabling studies.
Envol Biomedical conducts advanced pharmacokinetic (PK) studies in nonhuman primates (NHPs), delivering precise ADME data through integrated surgical, analytical, and digital modeling expertise.
Envol Biomedical delivers GLP and non-GLP toxicology programs in nonhuman primates (NHPs), combining regulatory rigor, surgical expertise, and real-time data reporting to accelerate IND readiness.
Envol Biomedical integrates advanced imaging technologies across preclinical programs to enhance surgical precision, disease modeling, and data interpretation in NHP studies.
Envol Biomedical’s in-house surgical team enables complex dosing, serial sampling, and targeted delivery in NHP studies with clinical-grade precision and cross-functional coordination.
Envol Biomedical’s Core Laboratory Services provide comprehensive analytical, bioanalytical, and molecular assay support that powers every pharmacology, PK, and toxicology study with speed, precision, and regulatory-grade data integrity.
Breeding & Colony Management
Envol maintains in-house breeding and colony management programs that ensure animal health, genetic integrity, and regulatory compliance; providing consistent, study-ready models for pharmacology, toxicology, and surgical research.
Envol Biomedical conducts indication- focused NHP studies across CNS, ocular, and respiratory therapeutic areas, combining surgical precision, validated models, and regulatory insight to accelerate translational drug development.
Envol Biomedical provides high-quality biological matrices—blood, tissues, cells, and biofluids—sourced through ODIN Bioscience and integrated into its GLP laboratory workflows for reliable, reproducible research outcomes.
Talk to an Expert About Our Research & Services
For inquiries about our research and services, don't hesitate to get in touch with our experts. Your journey to innovation starts here.